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Abstract
Polymorphonuclear leukocytes (PMNs) are recruited to sites of injury and biomaterial implants. 
Once activated, PMNs can exocytose their granule subsets to recruit monocytes (MCs) and 
mediate MC/macrophage activation. We investigated the release of myeloperoxidase (MPO), a 
primary granule marker, and matrix metalloproteinase-9 (MMP-9), a tertiary granule marker, from 
human blood-derived PMNs cultured on poly(ethylene glycol) (PEG) hydrogels, 
polydimethylsiloxane (PDMS), tissue culture polystyrene (TCPS) and gelatin-PEG (GP) 
hydrogels, with and without the presence of the bacterial peptide formyl-Met-Leu-Phe. 
Supernatants from PMN cultures on PEG-containing hydrogels (i.e., PEG and GP hydrogels) had 
higher concentrations of MPO than those from PMN cultures on PDMS or TCPS at 2 hours. 
PMNs on all biomaterials released comparable levels of MMP-9 at 2 hours, indicating that PMNs 
cultured on PEG-containing hydrogels have different mechanisms of release for primary and 
tertiary granules. Src family kinases were involved in the release of MPO from PMNs cultured on 
PEG hydrogels, TCPS and GP hydrogels and in the release of MMP-9 from PMNs cultured on all 
four materials. The increased release of primary granules from PMNs on PEG-containing 
hydrogels did not significantly increase MC chemotaxis, indicating that additional co-effectors in 
the dynamic inflammatory milieu in vivo modulate PMN-mediated MC recruitment.
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INTRODUCTION
Implantation of a biomaterial initiates a series of inflammatory and wound healing events 
collectively termed the foreign body response (FBR), during which polymorphonuclear 
leukocytes (PMNs; neutrophils) extravasate to the implant site in response to injury to 
vascular tissue.1,2 PMNs contain four subsets of granule proteins, formed sequentially based 
on the biosynthetic capabilities of the cell at the given stage of myelopoeisis (Supplementary 
Figure 1).3 These subsets include primary granules, secondary granules, tertiary granules 
and secretory vesicles.4 There are nearly 300 granule proteins, including antimicrobial 
proteins, proteases, β2-integrin receptors, chemotactic receptors and soluble mediators of 
inflammation.5,6 Upon receptor-mediated activation, PMNs can release their granule subsets 
to facilitate monocyte (MC) chemotaxis and mediate MC/macrophage activation and 
function,7–18 thereby influencing subsequent inflammatory or wound healing events in the 
FBR.
To better understand how biomaterials modulate PMN-MC paracrine interactions, in a 
previous study, we cultured human blood-derived MCs on poly(ethylene glycol) (PEG) 
hydrogels, polydimethylsiloxane (PDMS) and tissue culture polystyrene (TCPS) and primed 
the MCs for 24 hours with conditioned media from cultures of autologous PMNs pre-
activated with matching biomaterials (PMN-conditioned media; PCM).19 PCM significantly 
increased MC viability/adhesion on PEG hydrogels.19 We hypothesized that biomaterial-
dependent PMN degranulation may contribute to the observed increase in MC viability/
adhesion upon treatment with PCM from PMN cultures on PEG hydrogels. Therefore, in 
this study, we sought to determine how biomaterials influence PMN degranulation events, as 
PMN granule proteins have implications for downstream inflammatory response. We 
focused on the release of primary and tertiary granules to investigate both early and late 
degranulation events. PMN primary granules contain toxic antimicrobial reagents such as 
myeloperoxidase (MPO), human neutrophil peptides 1–3 (HNP1–3), cathepsin G and 
elastase, and are generally released only after PMN extravasation to the site of 
inflammation.16 PMN tertiary granules contain matrix-degrading enzymes such as matrix 
metalloproteinase-9 (MMP-9) and are released when PMNs transmigrate through the 
endothelium on their journey to the site of inflammation.16 Proteases such as elastase, 
cathepsin G and MMP-9 are involved in tissue remodeling in inflammation but are also 
involved in tissue pathology in inflammatory diseases.20–22 In addition to the biomaterials 
we used in our previous study (PEG hydrogels, PDMS and TCPS),19 we also investigated 
gelatin-PEG (GP) hydrogels, which are a hybrid biomatrix developed in our group based on 
the thiol-ene reaction of PEG diacrylate and cysteine/PEG-modified gelatin.23 The 
incorporation of gelatin in the hydrogel introduces cell-binding motifs such as RGD 
(arginine-glycineaspartic acid) peptides and could possibly regulate MMP expression.
MATERIALS AND METHODS
PEG hydrogel, GP hydrogel, PDMS and TCPS preparation
PEG diacrylate (molecular weight 3350) and cysteine/PEG-modified gelatin (gel-PEG-cys) 
were synthesized as previously described23 and characterized by proton NMR (Varian 
Unity-Inova 400 MHz; Varian Inc., Palo Alto, CA). The proton NMR spectrum of PEG 
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diacrylate in deuterated chloroform showed peaks at 3.6, 3.7 and 4.3 ppm (methylene 
protons), and 5.8, 6.2 and 6.4 ppm (acrylate protons). PEG diacrylate products were 
routinely found to have > 85% acrylation based on proton NMR peak area measurements. 
The proton NMR spectrum of gel-PEG-cys in deuterated water showed peaks at 1.3 ppm (d, 
2H, -CH2SH), 2.9 ppm (t, 1H, -CHCH2SH), 3.7 ppm (m, -CH2- from PEG backbone) and 
broad gelatin peaks at 1.7, 1.8, 1.9, 3.2 and 4.2 ppm. PEG hydrogels were prepared by 
dissolving 10 weight percent PEG diacrylate (molecular weight 3350) and 0.1 weight 
percent 2-hydroxy-4'-(2-hydroxyethoxy)-2-methylpropiophenone (Sigma-Aldrich, St. Louis, 
MO) in water with heat (37°C). GP hydrogels were prepared by dissolving 10 weight 
percent PEG diacrylate (molecular weight 3350), 0.1 weight percent 2-hydroxy-4'-(2-
hydroxyethoxy)-2-methylpropiophenone and 10 weight percent gel-PEG-cys in water with 
heat (37°C). The PEG and GP hydrogel solutions were injected into Teflon molds held 
between two, pre-cleaned glass slides and polymerized by placing the assemblies under a 
UV light (UV CF1000 LED, λmax = 365 nm; Clearstone Technologies, Minneapolis, MN) 
for 3 minutes per side. The PEG and GP hydrogel films were cold sterilized in 70% ethanol 
(Decon Labs, Inc., King of Prussia, PA) for 45 minutes and equilibrated overnight in 
Dulbecco's phosphate-buffered saline (DPBS; Cellgro, Manassas, VA). The PEG and GP 
hydrogel films were cut into 8-mm diameter disks with biopsy punches (Miltex, Inc., York, 
PA), placed into 48-well culture plates (Corning Inc., Corning, NY) and cold sterilized in 
70% ethanol for 45 minutes.
PDMS (0.762 mm thickness, non-reinforced vulcanized gloss/gloss; Specialty 
Manufacturing Inc., Saginaw, MI) was cut into 8-mm diameter disks with biopsy punches 
and sonicated for 10 minutes in a 0.5 weight percent solution of sodium dodecyl sulfate 
(Amresco, Solon, OH). The PDMS disks were rinsed with deionized water, placed into 48-
well culture plates and cold sterilized in 70% ethanol for 45 minutes. Sterilized PEG 
hydrogels, GP hydrogels and PDMS disks were washed three times with DPBS and 
equilibrated in RPMI-1640 basal medium (Cellgro, Manassas, VA) prior to seeding with 
cells. TCPS wells (Corning Inc., Corning, NY) were also washed three times with DPBS 
and equilibrated in RPMI-1640 medium prior to cell seeding.
Culture of human blood-derived PMNs and MCs
Peripheral whole blood was obtained from consenting healthy adult donors in accordance 
with protocols approved by the University of Wisconsin-Madison Institutional Review 
Board. PMNs and MCs were isolated as previously described using a gradient method.24 A 
small percentage (<1%) of basophils and eosinophils are possible in the PMN isolation. The 
MC isolation procedure routinely results in approximately 80–90% MC purity with 
lymphocytes as the primary impurities. PMNs were adjusted to 1 × 106 cells/ml in 
RPMI-1640 medium supplemented with 10% autologous human serum (AHS). The PMN 
suspension was split into two groups where one group received 100 nM of the bacterial 
peptide formyl-Met-Leu-Phe (fMLP; Sigma-Aldrich, St. Louis, MO). This concentration of 
fMLP is used to stimulate PMN degranulation.25 PMNs were statically seeded onto PEG 
hydrogel, PDMS, TCPS and GP hydrogel surfaces in 48-well plates (0.5 ml/well for a 
density of approximately 5.3 × 103 PMNs/mm2) and were incubated in a humidified 
atmosphere at 37°C with 5% CO2 for between 2 and 24 hours. MCs were adjusted to 1.7 × 
Cohen et al. Page 3
J Biomed Mater Res A. Author manuscript; available in PMC 2015 December 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
106 cells/ml in RPMI-1640 medium supplemented with 10% AHS and were seeded as 
described below for the MC chemotaxis assay.
Analysis of cell adhesion and viability
At pre-determined time points, the culture media was aspirated from PMN cultures and 
replaced with a solution containing 4 μM green-fluorescent calcein AM and 2 μM red-
fluorescent ethidium homodimer-1 (reagents from LIVE/DEAD Viability/Cytotoxicity Kit; 
Molecular Probes, Eugene, OR) in DPBS. The PMN cultures were then incubated for 45 
minutes in a humidified atmosphere at 37°C with 5% CO2. Three representative fields per 
well of a 48-well plate were imaged at 10× magnification with a digital camera attached to 
an inverted fluorescent microscope (Nikon Eclipse TE 300; Nikon Instruments Inc., 
Melville, NY). Viable (green) and necrotic (red) cells were counted in an area of 0.62 mm2 
per field to determine adherent viable and necrotic cell densities (cells/mm2). Metabolic 
capacity was measured using CellTiter-Blue® Reagent (Promega Corporation, Madison, 
WI) as an indicator of cell viability; CellTiter-Blue® Reagent contains a redox dye 
(resazurin) that can be converted into a fluorescent product (resofurin) by metabolically 
active cells. At 2 and 4 hours, the culture media was aspirated from PMN cultures (seeded at 
a density of approximately 5.3 × 103 PMNs/mm2) and replaced with a solution containing 
10% CellTiter-Blue® Reagent in RPMI-1640 medium supplemented with 10% AHS. PMN 
cultures containing the CellTiter-Blue® Reagent were incubated for 4 hours in a humidified 
atmosphere at 37°C with 5% CO2. The culture media was then transferred to wells in a 96-
well plate (Corning Inc., Corning, NY) and the fluorescent signal (584 nm excitation, 620 
nm emission) was measured using a plate reader (FLUOstar OPTIMA; BMG Labtech, Cary, 
NC). Fluorescent intensities (FI) of PMN samples were normalized to biomaterial control 
samples that did not contain cells.
Measurement of MPO and MMP-9
After 2 and 4 hours, supernatants (i.e., PCM) from PMN cultures on the biomaterials 
(seeded at a density of approximately 5.3 × 103 PMNs/mm2) were collected and centrifuged 
at 2500 × g for 10 minutes at 4°C to remove cells and cellular debris. These two time points 
were selected for measurement of MPO and MMP-9 based on an initial experiment in which 
adherent viable and necrotic cell densities were quantified after PMNs were cultured on the 
same four biomaterials with and without 100 nM fMLP for 1, 2, 4, 6, 12 and 24 hours. 
Compared to the other time points, at 2 and 4 hours, adherent viable cell densities on the 
biomaterials were high and necrotic adherent cell densities were low (Supplementary Figure 
2).
MPO in supernatants from PMN cultures was measured using an enzyme-linked 
immunosorbent assay (ELISA) kit (Hycult Biotech, Plymouth Meeting, PA) or a Milliplex® 
bead-based immunoassay kit (EMD Millipore, Billerica, MA) according to manufacturer's 
instructions. MPO is a primary granule protein that catalyzes the formation of hypochlorous 
acid from hydrogen peroxide and chloride anion. MMP-9 in supernatants from PMN 
cultures was measured using a Milliplex® bead-based immunoassay kit (EMD Millipore, 
Billerica, MA) according to manufacturer's instructions. MMP-9 (gelatinase) is a tertiary 
granule protein that is involved in the degradation of extracellular matrix proteins such as 
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gelatin and collagen type IV. PCM samples were diluted between 4- and 200-fold to stay 
within the measureable range of the MPO and MMP-9 assays.
PMN pre-treatment with Src family kinase inhibitor PP1
After isolation, PMNs were suspended at a concentration of 2 × 106 cells/ml in RPMI-1640 
medium supplemented with 10% AHS and 10 μM Src family kinase inhibitor PP1 (4-
amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo-d-3,4-pyrimidine; EMD Millipore, Billerica, 
MA) or an equivalent volume of dimethyl sulfoxide (Sigma-Aldrich, St. Louis, MO). The 
PMNs were then statically seeded onto PEG hydrogel, PDMS, TCPS and GP hydrogel 
surfaces in 48-well plates (0.25 ml/well for a density of approximately 5.3 × 103 PMNs/
mm2). The plates were incubated in a humidified atmosphere at 37°C with 5% CO2 for 10 
minutes. After 10 minutes, an additional 250 μl of RPMI-1640 medium supplemented with 
10% AHS was added to the wells and the well plates were incubated for 2 hours in a 
humidified atmosphere at 37°C with 5% CO2. After 2 hours, cell adhesion and viability, 
MPO, and MMP-9 were measured as described above.
MC chemotaxis assay
At 2 hours, PCM from PMN cultures on the biomaterials (seeded at a density of 
approximately 5.3 × 103 PMNs/mm2) were collected and centrifuged at 2500 × g for 10 
minutes at 4°C to remove cells and cellular debris. This time point was selected for 
collection of PCM for the MC chemotaxis assay due to the increased concentrations of MPO 
in PCM from PMN cultures on PEG and GP hydrogels at 2 hours. The PCM 
chemoattractant solutions were added to the bottom wells of 96-well ChemoTx® 
chemotaxis plates (Neuro Probe, Inc., Gaithersburg, MD). Control chemoattractant solutions 
(i.e., 10% AHS in RPMI-1640 medium without fMLP and 10% AHS in RPMI-1640 
medium with 50 or 100 nM fMLP) were also added to the bottom wells of the chemotaxis 
plates. A polycarbonate filter with 5-μm diameter pores was placed on top of the wells and 
approximately 4.2 × 104 autologous MCs were placed in each well site on the top of the 
filter for a density of approximately 5.3 × 103 MCs/mm2. The chemotaxis plate was covered 
and incubated for 90 minutes in a humidified atmosphere at 37°C with 5% CO2, during 
which time MCs could transmigrate to the underside of the filter in response to the 
chemoattractant solutions in the bottom wells. After 90 minutes, the filter was removed and 
non-migrated MCs were scraped from the top side of the filter. The filter was then fixed and 
stained using a modified Wright-Giemsa stain (HEMA 3® Stain Set; Fisher Scientific 
Company, Middletown, VA). One representative field per filter site was imaged at 10× 
magnification with a digital camera attached to an optical microscope (Leica DMLB 
Microscope Type 11888010; Leica Microsystems GmbH, Wetzlar, Germany). 
Transmigrated MCs were counted in an area of 0.13 mm2 per field.
Statistical analysis
Unless otherwise indicated, each experiment was performed four times, using four different 
blood donors (n = 4) and data are shown as mean ± standard deviation. Statistical analysis 
was performed using one- or two-way analysis of variance (ANOVA) combined with 
Bonferroni's multiple comparison post tests (GraphPad Prism, San Diego, CA). Values of p 
≤ 0.05 were considered statistically significant.
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RESULTS
PMN-biomaterial interactions: cell adhesion and viability
There were no significant differences in viable or necrotic adherent cell densities due to the 
addition of 100 nM fMLP in the culture medium (Figure 1). However, the addition of 100 
nM fMLP to the culture medium significantly increased cell viability based on metabolic 
capacity for PMNs on PDMS and TCPS at 2 hours (p = 0.01–0.05) (Figure 2). At 4 hours 
without fMLP, necrotic cell densities were significantly higher on PDMS than on PEG 
hydrogels (p = 0.01–0.05) (Figure 1A). In agreement, cell viability on PDMS at 4 hours 
without fMLP was lower than on the other materials (Figure 2A). Furthermore, at 2 hours 
with 100 nM fMLP, cell viability on PDMS was significantly lower than that on PEG 
hydrogels or TCPS (p = 0.01–0.05) (Figure 2B). There were no significant differences in 
total (viable + necrotic) adherent cell densities among materials at 2 or 4 hours with or 
without the addition of fMLP (Figure 1).
PEG-containing hydrogels promote the release of MPO, but not MMP-9 from PMNs
At 2 hours, supernatants from PMN cultures on PEG hydrogels had significantly higher 
MPO concentrations than those from PMN cultures on PDMS or TCPS (p = 0.001–0.05) 
(Figure 3). There were also higher MPO concentrations in supernatants from PMN cultures 
on GP hydrogels than in those from PMN cultures on PDMS or TCPS. The addition of 100 
nM fMLP to the culture medium significantly increased MPO concentrations in supernatants 
from PMN cultures on TCPS at 2 hours (from 64 ± 29 ng/ml on TCPS without fMLP to 325 
± 51 ng/ml on TCPS with 100 nM fMLP) (p = 0.01–0.05). MPO concentrations in 
supernatants from PMNs cultures without fMLP on PEG and GP hydrogels decreased 
significantly between 2 and 4 hours (p = 0.0001–0.001). MPO concentrations in 
supernatants from PMN cultures with 100 nM fMLP on PEG hydrogels, PDMS, TCPS and 
GP hydrogels also decreased significantly between 2 and 4 hours (p < 0.01). This reduction 
in MPO between 2 and 4 hours suggests that MPO in the culture media may degrade, adhere 
to the biomaterials or complex with serum proteins.
The release of MMP-9 from PMNs cultured on the biomaterials did not follow the same 
trend as the release of MPO: at 2 hours there were no significant differences in MMP-9 
concentrations among biomaterials (Figure 4). However, in PMN cultures on GP hydrogels 
with 100 nM fMLP, MMP-9 concentrations in supernatants decreased significantly between 
2 and 4 hours (p = 0.01–0.05), resulting in significantly lower MMP-9 concentrations in 
supernatants from PMNs cultures on GP hydrogels than in those from PMN cultures on PEG 
hydrogels, PDMS or TCPS at 4 hours (p = 0.0001–0.01). Because gelatin is a substrate of 
MMP-9, MMP-9 released from PMNs may have been actively cleaving the gelatin in the GP 
hydrogels and therefore was not as freely available in the culture media to be detected by 
immunoassay.
Pre-treatment with Src family kinase inhibitor PP1 decreases MPO and MMP-9 release from 
PMNs
To determine the role of Src family kinases in biomaterial-mediated PMN degranulation, we 
pre-treated PMNs cultured on the biomaterials with PP1, a Src family kinase inhibitor. The 
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addition of 10 μM PP1 to the culture medium significantly decreased MPO release from 
PMNs cultured on PEG hydrogels, TCPS and GP hydrogels (p = 0.0001–0.01) (Figure 5) 
and significantly decreased MMP-9 release from PMNs cultured on all four materials (p < 
0.01) (Figure 6). To confirm that the PP1-mediated decreases in MPO and MMP-9 release 
were not due to changes in cell adhesion or viability, we also measured adherent viable and 
necrotic cell densities and cell viability based on metabolic capacity. The addition of 10 μM 
PP1 to the culture medium did not significantly influence adherent viable PMN densities 
(Supplementary Figure 3A), but did decrease adherent necrotic PMN densities on PDMS (p 
< 0.0001) (Supplementary Figure 3B), suggesting that the addition of PP1 decreased PMN 
death on PDMS. The addition of 10 μM PP1 to the culture medium decreased PMN viability 
based on metabolic capacity on GP hydrogels (p = 0.001–0.01), but did not affect PMN 
viability on PEG hydrogels, PDMS or TCPS (Supplementary Figure 4). Overall, these 
results suggest that PP1 minimally influences PMN adhesion and viability. Therefore, it is 
likely that the PP1-mediated decreases in primary and tertiary granule release are not a 
consequence of PP1-mediated changes in cell viability or adhesion.
Effect of PMN granular content on MC chemotaxis
There were no significant differences in MC transmigration in response to autologous PCM 
from PMN cultures on any of the four biomaterials with or without fMLP (Supplementary 
Figure 5). Additionally PCM did not significantly increase MC transmigration as compared 
with the 10% AHS culture medium baseline. However, compared to the other materials and 
the 10% AHS baseline, there were slight increases in MC transmigration in response to 
PCM from PMN cultures on PEG hydrogels with and without fMLP. There were also slight 
increases in MC transmigration due to the presence of fMLP in chemoattractant solutions 
from PMN cultures on GP hydrogels. Lastly, compared with the 10% AHS baseline, there 
were slight elevations in MC transmigration in response to 10% AHS with 50 nM fMLP.
DISCUSSION
PEG-containing hydrogels promote primary granule release from PMNs
PMN degranulation generally occurs in a stepwise manner, with secretory vesicles 
exocytosed most readily, followed by tertiary, secondary, and finally, primary granules, 
which are the most tightly regulated due to their abundance of toxic microbicidal 
substances.26 Therefore, a major finding in our study was that PEG and GP hydrogels were 
sufficiently activating to induce the release of primary granules from PMNs at 2 hours. 
Furthermore, PMNs on PEG hydrogels had significantly greater release of primary granules 
than PMNs on PDMS or TCPS at 2 hours. Similarly, in a previous study we found that at 2 
hours, supernatants from PMN cultures on PEG hydrogels had significantly higher 
concentrations of HNP1–3 than those from PMN cultures on PDMS or TCPS.19 The 
enhanced release of primary granule proteins from PMNs on PEG hydrogels may account 
for the significant increase in MC viability/adhesion that we previously observed upon 
addition of PCM to MC cultures on PEG hydrogels,19 perhaps by modifying protein 
adsorption on PEG hydrogels or by acting as soluble signals for MCs to increase viability 
and adhesion. While we do see lower viable adherent PMN densities on PEG and GP 
hydrogels, we do not believe that leakage of cell contents from nonadherent PMNs is 
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responsible for the increased primary granule release from PMNs on PEG and GP 
hydrogels. We previously observed that secondary necrosis (as measured by caspase 3/7 
activity in cell culture supernatants) of PMNs on PEG hydrogels was comparable to that of 
PMNs on PDMS at 2 hours19, thereby suggesting that secondary necrosis of nonadherent 
PMNs (and thus leakage of cell contents) does not contribute to the observed primary 
granule release from PMNs on PEG and GP hydrogels.
PEG is traditionally considered to be protein resistant and bioinert.27–30 However, studies 
from our group and others have shown that MC/macrophages have increased pro-
inflammatory cytokine expression (e.g., IL-1β and TNF) when cultured on PEG hydrogels in 
vitro.19,24,31,32 Furthermore, Lynn et al. demonstrated that implantation of PEG hydrogels in 
mice resulted in a robust inflammatory reaction characterized by a dense layer of 
macrophages at the biomaterial surface.31 The results from our study suggest that like MC/
macrophages, PMNs may also undergo an inflammatory response to PEG-containing 
hydrogels.
It is plausible that post-integrin-ligation signaling events regulate the release of primary 
granules from PMNs adherent on PEG and GP hydrogels. While much research on PMN 
degranulation involves PMNs in suspension, some reports focused on adhesion-dependent 
degranulation (graphically summarized in Figure 7). Ligation of the β2-integrin CD11b/
CD18 (Mac-1) is responsible for spontaneous oscillations of cytosolic free Ca2+ in adherent 
PMNs33 and these oscillations were shown to be involved in TNF-induced release of 
secondary granules from adherent PMNs.34 Tyrosine kinases Syk and Pyk2 and Src family 
kinases have also been implicated in integrin-mediated degranulation of adherent PMNs. 
Wild-type murine PMNs adherent on fibrinogen-coated surfaces released secondary 
granules in response to TNF stimulation, whereas Syk-deficient murine PMNs on 
fibrinogen-coated surfaces did not release secondary granules in response to TNF 
stimulation.35 Pyk2-deficient murine PMNs plated on poly-RGD surfaces and treated with 
TNF had reduced release of secondary and tertiary granules when compared with wild-type 
PMNs.36 Additionally, Src family kinases were required for the release of secondary 
granules from PMNs adherent on fibrinogen-coated surfaces and treated with TNF.37 Based 
on these reports, we hypothesized that Src family kinases and their downstream tyrosine 
kinases may also be involved in the release of primary granules from PMNs adherent on 
PEG and GP hydrogels. In experiments using the Src family kinase inhibitor PP1, we 
determined that Src family kinases are involved in primary granule release from PMNs on 
PEG hydrogels, TCPS and GP hydrogels, but not in primary granule release from PMNs on 
PDMS. Because Src family kinases were involved in primary granule release from PMNs on 
TCPS, it does not appear that differences in Src family kinase-mediated signaling are 
responsible for the increased primary granule release from PMNs on PEG and GP 
hydrogels.
Differing serum protein adsorption on PEG and GP hydrogels compared to that on PDMS 
and TCPS may lead to the increased primary granule release from PMNs cultured on PEG 
and GP hydrogels. However, we did not observe a correlation between PMN adhesion and 
release of primary granules, suggesting that if there are unique serum protein adsorption 
profiles on PEG and GP hydrogels, they are not reflected in PMN adhesion on these 
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materials. PMNs cultured on fibronectin-, fibrinogen- and albumin-coated surfaces showed 
minimal spontaneous primary granule release,38 suggesting that PMN adhesion to 
fibronectin, fibrinogen or albumin adsorbed on PEG and GP hydrogels is not responsible for 
the primary granule release observed in our study. In addition, Wang et al. showed that PEG 
hydrogels had significantly lower adsorption of vitronectin, thrombin, fibrinogen, and 
complement component C3 than TCPS,28 suggesting that these proteins are also not 
involved in the release of primary granules from PMNs cultured on PEG hydrogels. 
Differences in adsorption of PMN granule proteins or less abundant serum proteins on PEG-
containing hydrogels may contribute to the increased primary granule release from PMNs on 
these materials. Unfortunately, studies investigating the adsorption of these less abundant 
proteins are challenging due to the interference of albumin and other highly abundant serum 
proteins.
PMNs cultured on PEG-containing hydrogels have different mechanisms of release for 
primary and tertiary granules
PEG-containing hydrogels (PEG and GP hydrogels) enhanced the release of MPO, but not 
MMP-9 from PMNs, suggesting that primary granule release from PMNs on PEG and GP 
hydrogels may be regulated differently than tertiary granule release. This is not surprising, 
as different signaling pathways have been implicated in degranulation of different granule 
subsets. For example, compared with wild-type murine PMNs in suspension, Rac2-deficient 
murine PMNs were unable to release primary granules in response to cytochalasin B (an 
inhibitor of actin filament polymerization) and fMLP treatment, but had normal secondary 
and tertiary granule release.39 In another example, Chakrabarti et al. demonstrated that 
blocking β2 integrins inhibited the release of secondary granules from TNF-stimulated 
human PMNs in suspension, but only partially attenuated the release of tertiary granules, 
suggesting that different pathways regulate secondary and tertiary granule release from 
suspended PMNs and that tertiary granule release uses β2-integrin-independent signaling 
pathways.40 If tertiary granule release in adherent PMNs also occurs independently of β2-
integrin signaling pathways, we would not expect to observe major differences in MMP-9 
release among the biomaterials due to their main differences involving PMN adhesion via β2 
integrins.
Adhesion-dependent PMN activation may be more likely to induce the release of primary 
granules than tertiary granules due to the involvement of the actin cytoskeleton in both 
adhesion and primary granule release. Mitchell et al. showed that stabilization of 
filamentous actin in PMNs with jasplakinolide, an actin filament stabilizing drug, inhibited 
primary granule release, but did not affect secondary granule release.41 Additionally, 
another study showed that disruption of the cytoskeleton with cytochalasin B allowed for the 
release of primary granules from fMLP-treated PMNs in suspension.39 Rac2, a Rho GTPase 
involved in actin remodeling, has also been implicated in the release of primary granules 
from PMNs, but not in the release of secondary or tertiary granules.39,41–43 These data 
suggest that tertiary granule release is regulated by a different pathway than primary granule 
release, which does not involve Rac2-mediated signaling or actin cytoskeletal remodeling. 
Pathways involving protein kinase C α and δ (PKCα and PKCδ) have been shown to be 
involved in tertiary granule release from TNF-stimulated human PMNs in suspension.40
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fMLP does not enhance degranulation from PMNs cultured on PEG-containing hydrogels 
or PDMS
fMLP is a bacterial peptide that activates PMNs through the fMLP receptor, a pertussis 
toxin-sensitive G-protein coupled receptor.44 We included fMLP treatment in the current 
study because others have suggested that full activation of PMNs requires two signals: 1) a 
signal generated from ligation of integrins and 2) a soluble pro-inflammatory stimulus (e.g., 
fMLP or TNF) or a signal from ligation of nonintegrin Fc receptors.35,45 For example, 
fMLP-induced primary granule release from human PMNs in suspension was increased in 
the presence of soluble fibrinogen, which binds to Mac-1, the main adhesion receptor in 
human PMNs.46 Additionally, Rainger et al. showed that fMLP induced the release of 
primary granules from surface-adherent PMNs, whereas no degranulation was observed 
from fMLP-treated PMNs in suspension.47 In agreement with the theory that two signals are 
needed for full activation of PMNs, in our studies, the addition of 100 nM fMLP to the 
culture medium significantly increased the release of primary granules from PMNs on TCPS 
at 2 hours. In contrast, at 2 hours on PEG hydrogels, PDMS and GP hydrogels and at 4 
hours on all materials, we did not observe a significant increase in the release of primary 
granules upon addition of 100 nM fMLP to the culture medium, suggesting that maximal 
primary granule release from PMNs was reached independently of secondary fMLP-
mediated signaling. Furthermore, fMLP did not enhance the release of tertiary granules from 
PMNs on any of the four biomaterials studied. Therefore, overall, our results indicate that 
biomaterial identity (i.e., physiochemical properties and/or associated proteins) largely 
dictates PMN activation and degranulation in lieu of the conventional “two-signal” 
activation mechanism.
Increased release of primary granules does not significantly enhance MC chemotaxis
We hypothesized that the increased release of primary granules from PMNs on PEG-
containing hydrogels may enhance MC chemotaxis due to the presence of MC chemotactic 
proteins in primary granules (e.g., azurocidin, cathepsin G, HNP1–3).7,10,13,18 However, the 
increased release of primary granules from PEG-containing hydrogels did not promote 
significant MC chemotaxis, although slight elevations in MC chemotaxis were observed in 
response to PCM from PMN cultures on PEG hydrogels when compared with the 10% AHS 
culture medium baseline. In our previous studies, we observed only selective, modest 
increases in pro-inflammatory cytokine release from MCs treated with PCM from 
biomaterial-activated PMN cultures,19 despite other studies showing that PMN granule 
proteins enhance pro-inflammatory cytokine release from MCs.11,12,48 Taken together, these 
data suggest that serum antiproteases such as α1 antichymotrypsin in the 10% AHS culture 
medium may inactivate certain primary granules proteins such as HNP1–3, elastase and 
cathepsin G,13,22,49 preventing these granule proteins from promoting MC chemotaxis or 
enhancing pro-inflammatory cytokine release from MCs. Nonetheless, it is possible that the 
inflammatory effects of PMN primary granule proteins may exist in vivo at areas of close 
contact between PMNs and MCs that exclude serum antiproteases. Furthermore, in vivo, 
additional co-effectors in the complex inflammatory milieu are likely involved in 
modulating PMN-mediated MC recruitment.15 For example, PMN granule proteins can 
activate endothelial cells to express cell adhesion molecules that enhance MC adhesion and 
can also induce endothelial cells to produce MC-attracting chemokines.50,51
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CONCLUSIONS
We have demonstrated that PEG-containing hydrogels promote the release of primary 
granules, but not tertiary granules from human blood-derived PMNs. Primary granules 
contain toxic microbicidal proteins, some of which are implicated in chronic inflammation. 
Divergent post-ligation signaling events of PMN integrin families and/or differing protein 
adsorption on the biomaterials may be responsible for the observed differences in the release 
of primary granules from PMNs cultured on PEG-containing hydrogels, as compared with 
PDMS or TCPS.
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Figure 1. 
Viable and necrotic adherent cell densities in PMN cultures A) without fMLP and B) with 
100 nM fMLP on PEG hydrogels, PDMS, TCPS and GP hydrogels at 2 and 4 hours as 
measured using calcein AM and ethidium homodimer-1 fluorescent stains. Results represent 
the mean + standard deviation, n = 4.
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Figure 2. 
Cell viability in PMN cultures A) without fMLP and B) with 100 nM fMLP on PEG 
hydrogels, PDMS, TCPS and GP hydrogels at 2 and 4 hours as measured by fluorescent 
intensity (FI) of cell metabolic capacity using CellTiter-Blue® Reagent. Results represent 
the mean ± standard deviation, n = 4. *: significant difference between materials, p = 0.01–
0.05.
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Figure 3. PEG-containing hydrogels promote the release of primary granules from PMNs
MPO concentrations in supernatants from PMN cultures on PEG hydrogels, PDMS, TCPS 
and GP hydrogels at 2 and 4 hours. Results represent the mean ± standard deviation with 
each data point representing a different donor, n = 4. *: significant difference between 
materials, p = 0.01–0.05; **: significant difference between materials, p = 0.001–0.01.
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Figure 4. 
MMP-9 concentrations in supernatants from PMN cultures on PEG hydrogels, PDMS, 
TCPS and GP hydrogels at 2 and 4 hours. Results represent the mean ± standard deviation 
with each data point representing a different donor, n = 4. **: significant difference from 
PEG hydrogel, PDMS and TCPS at the same time point, p = 0.0001–0.01.
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Figure 5. 
MPO concentrations in supernatants from PMN cultures pre-treated with 10 _M PP1 on 
PEG hydrogels, PDMS, TCPS and GP hydrogels at 2 hours. Results represent the mean ± 
standard deviation with each data point representing a different donor, n = 4. **: significant 
difference with PP1 pre-treatment, p = 0.001–0.01; ***: significant difference with PP1 pre-
treatment, p = 0.0001–0.001.
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Figure 6. 
MMP-9 concentrations in supernatants from PMN cultures pre-treated with 10 _M PP1 on 
PEG hydrogels, PDMS, TCPS and GP hydrogels at 2 hours. Results represent the mean ± 
standard deviation with each data point representing a different donor, n = 4. **: significant 
difference with PP1 pre-treatment, p = 0.001–0.01; ***: significant difference with PP1 pre-
treatment, p = 0.0001–0.001; ****: significant difference with PP1 pre-treatment, p < 
0.0001.
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Figure 7. Adhesion-dependent PMN degranulation
In Mac-1-mediated signaling, Src family kinases activate non-receptor tyrosine kinases Syk 
and Pyk2 by tyrosine phosphorylation.52–54 From top left to bottom right: TNF-induced 
release of secondary granules from adherent human PMNs is dependent on Mac-1-integrin-
triggered oscillations of cytosolic free Ca2+.34 Src family kinases are involved in the 
spontaneous release of secondary granules from human PMNs adherent on TCPS.37 Syk is 
involved in the release of secondary granules from murine PMNs adherent on fibrinogen-
coated surfaces in response to TNF stimulation.35 Pyk2 is involved in the TNF-induced 
release of secondary and tertiary granules from murine PMNs adherent on poly-RGD 
surfaces.36 Bold boxes: In this study, we found that Src family kinases are involved in the 
spontaneous release of primary granules from PMNs cultured on PEG hydrogels, TCPS and 
GP hydrogels and that Src family kinases are also involved in the spontaneous release of 
tertiary granules from PMNs cultured on PEG hydrogels, PDMS, TCPS, and GP hydrogels.
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